ISRCTN56416473已完成不适用
A multicentre randomised trial of short neo-adjuvant chemotherapy (VAPEC-B) plus involved field radiotherapy (MIT) versus mantle radiotherapy
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients aged between 16 and 75 years
- •2. Histologically proven Hodgkin's disease, stage IA or IIA with no mediastinal bulk
- •3. No previous treatment
- •4. No previous malignancy other than basal cell carcinoma or cervical intra-epithelial neoplasms
- •5. No concurrent illness which would contraindicate chemotherapy or radiotherapy
- •6. Not documented evidence of Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS)
排除标准
- •If Hodgkin's disease is below the diaphragm only, patients are not eligible for this trial
研究者
相似试验
尚未招募
3 期
Study to compare the longevity of life between using low-dose immunotherapy before surgery and only surgery alone for advanced stage oral cancerCTRI/2024/04/065574Tata Memorial Centre
进行中（未招募）
不适用
Phase II Study of neoadjuvant Trastuzumab+Docetaxel+/-Bevacizumab and Trastuzumab+Docetaxel+NPLD +/-Bevacizumab in HER2-positive Early Breast Cancer (ABCSG32)HER2-positive, adenocarcinoma of the breast (except inflammatory breast cancer, T4d)EUCTR2010-023324-25-ATABCSG (Austrian Breast & Colorectal Cancer Study Group)100
进行中（未招募）
1 期
A clinical trial for people who have cancer of the food pipe and junction of the food pipe and stomach, to compare chemotherapy before and after surgery, with chemotherapy with radiotherapy before surgery.Adenocarcinoma of the oesophagus and oesophago-gastric junctionMedDRA version: 21.1Level: LLTClassification code 10007445Term: Carcinoma of oesophagus NOSSystem Organ Class: 100000004864EUCTR2011-001858-28-GBCancer Trials Ireland Company Limited By Guarantee540
进行中（未招募）
3 期
eo Adjuvant Chemotherapy in Triple Negative Breast CancerCTRI/2012/07/002802Tata Memorial Centre
进行中（未招募）
不适用
A multicenter Phase II clinical trial of neoadjuvant trabectedin (Yondelis) in patients with localized myxoid / round cell liposarcoma. - NDocalized myxoid / round cell liposarcoma (MRCL).MedDRA version: 6.1Level: PTClassification code 10024630EUCTR2007-000035-25-ITPHARMA MAR22